Invasive pulmonary aspergillosis in a patient with seminomatous testicular cancer.

Abstract

In the past years there has been an increasing incidence of invasive fungal infections, particularly in immunocompromised patients. These infections continue to pose a diagnostic and therapeutic challenge. Considering these facts, the authors report a clinical case of invasive pulmonary aspergillosis which illustrates the improved outcomes associated with the extended-spectrum triazole, voriconazole, used in first-line therapy.

• Authors: Sandra Saleiro, Luís Rocha
• Journal: Mycoses (Mycoses) Vol. 54 Suppl 4 Pg. 16-9 (Dec 2011) ISSN: 1439-0507 [Electronic] Germany
• PMID: 22126525 (Publication Type: Case Reports, Journal Article)
• Copyright: © 2011 Blackwell Verlag GmbH.

Chemical References

• Antifungal Agents
• Antineoplastic Agents
• Pyrimidines
• Triazoles
• Voriconazole

Topics

• Adult
• Antifungal Agents (administration & dosage)
• Antineoplastic Agents (administration & dosage, adverse effects)
• Humans
• Immunocompromised Host
• Invasive Pulmonary Aspergillosis (diagnosis, drug therapy)
• Male
• Pyrimidines (administration & dosage)
• Testicular Neoplasms (complications, drug therapy)
• Treatment Outcome
• Triazoles (administration & dosage)
• Voriconazole